Premium
Intestinal amoebiasis in a patient with acute graft‐versus‐host disease after allogeneic bone marrow transplantation successfully treated by metronidazole
Author(s) -
Numata A.,
Itabashi M.,
Kishimoto K.,
Motohashi K.,
Hagihara M.,
Kuwabara H.,
Tanaka M.,
Kato H.,
Chiba S.,
Kunisaki R.,
Fujisawa S.
Publication year - 2015
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12460
Subject(s) - medicine , metronidazole , amoebiasis , leukemia , transplantation , myeloid leukemia , hematopoietic stem cell transplantation , bone marrow , immunology , graft versus host disease , antibiotics , biology , microbiology and biotechnology
Amoebiasis has rarely been reported in patients undergoing hematopoietic stem cell transplantation, although it is a world‐wide infection and extremely common. We present a case of intestinal amoebiasis unexpectedly revealed by colonoscopy after allogeneic bone marrow transplantation from a human leukocyte antigen‐mismatched unrelated donor for acute myeloid leukemia arising from chronic myelomonocytic leukemia and successfully treated by metronidazole.